Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Cucurmin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 159Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Top Turmeric & Curcumin Supplement In 2026: Buyer's Guide &
    Top Turmeric & Curcumin Supplement In 2026: Buyer's Guide &

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/best-turmeric-and-curcumin-supplement-in-2026-buyer-s-guide-and-review

    PHARMIWEB
    09 Feb 2026
    Share Share
    Vascarta & CUNY Achieve Preclinical Glioblastoma Treatment
    Vascarta & CUNY Achieve Preclinical Glioblastoma Treatment

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-and-cuny-report-preclinical-breakthrough-in-glioblastoma-treatment-302608991.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Vascarta Interrupts Neuroinflammatory Cascade In Acute Sickle
    Vascarta Interrupts Neuroinflammatory Cascade In Acute Sickle

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-inc-transdermal-curcumin-vas-101-drug-candidate-interrupts-the-neuroinflammatory-pathophysiological-cascade-associated-with-acute-sickle-cell-crisis-302602960.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Greenspace Herbs Reveals Quantum Ayurveda At Supplyside Global
    Greenspace Herbs Reveals Quantum Ayurveda At Supplyside Global

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163780/0/en/Greenspace-Herbs-Unveils-Physics-Driven-Quantum-Ayurveda-at-SupplySide-Global.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Vascarta Partners with NIH for Phase 1 study of VAS-101
    Vascarta Partners with NIH for Phase 1 study of VAS-101

    07 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/national-heart-lung-and-blood-institute--national-institutes-of-health-signs-clinical-trial-agreement-with-vascarta-inc-to-perform-phase-1-clinical-study-of-vas-101-in-sickle-cell-disease-302498504.html

    PR NEWSWIRE
    07 Jul 2025
    Share Share
    Vascarta starts Phase 1 Study of VAS-101 in sickle cell disease
    Vascarta starts Phase 1 Study of VAS-101 in sickle cell disease

    15 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-commences-proof-of-concept-phase-1-clinical-study-of-vas-101-in-sickle-cell-disease-in-the-united-states-302428782.html

    PR NEWSWIRE
    15 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.